CoverageForm 410-K10-Q8-K13D13G13F

Hoppenot Herve

CIK 0001596492
Special Advisor to the CEODirector

Filings

18

Latest Jan 6, 2026

Issuers covered

3

Showing

18 of 18

Page 1

Track record

1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

HorizonTradesWin rateAvgMedianBestWorst
30 days1100%+10.2%+10.2%+10.2%+10.2%
90 days10%-2.9%-2.9%-2.9%-2.9%
180 days1100%+5.3%+5.3%+5.3%+5.3%
365 days------

Issuers

Companies where Hoppenot Herve has filed

TickerIssuerFilingsLast filed
INCYIncyte Corp15Dec 10, 2025
BCYCBicycle Therapeutics PLC2Jan 6, 2026
MAZEMaze Therapeutics, Inc.1Oct 7, 2025

All filings

18 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue